Administration of all-trans retinoic acid through enteral tubes in acute promyelocytic leukemia: the handling of cytotoxic agents and clinical benefits
AUTOR(ES)
Okumura, Lucas Miyake, Baruel Okumura, Patrícia Carvalho, Veroneze, Cleni
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2017-03
RESUMO
Documentos Relacionados
- All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
- 4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal
- All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
- A mammalian homolog of unc-53 is regulated by all-trans retinoic acid in neuroblastoma cells and embryos
- Hyaluronic acid-coated nanoemulsions loaded with a hydrophobic ion pair of all-trans retinoic acid for improving the anticancer activity